OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

To reveal more filter options, please select whether you would like to review Active or Closed projects:

Clear
Organization: Georgetown University

4 Projects | 4 Researchers | $2,442,500 Invested

2015

Georgetown University

Raymond Turner, MD, PhD

Therapeutic Effects of Nilotinib in Alzheimer's Disease Patients

  • Funding Amount: $2,104,000
  • Organization Type: Academic/Nonprofit
  • Program: Clinical
  • Target: Proteostasis
  • Status: Closed

2013

Georgetown University

Xiong Jiang, PhD

A novel fMRI biomarker of asymptomatic Alzheimer's disease

  • Funding Amount: $140,000
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Closed

2003

Georgetown University

Yasuji Matsuoka, PhD

Development of Abeta-Binding Agents for Abeta Sequestration Therapy

  • Funding Amount: $98,500
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed

2000

Georgetown University

Alan Faden, MD

Modulation of Beta-Amyloid Induced Neuronal Apoptosis by Selective Activation of Metabotrophic Glutamate Receptors

  • Funding Amount: $100,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed